Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ovaria comp
- Development stage
- Phase 4
- Lead developer
- WALA Heilmittel
- Administration
- Oral
01
Overview
Ovaria comp is a homeopathic complex preparation traditionally used in anthroposophic medicine to treat functional disorders of the female reproductive system, particularly climacteric (menopausal) symptoms such as hot flashes, mood swings, and sleep disturbances. Developed and manufactured by WALA Heilmittel GmbH, the preparation typically contains a combination of ingredients including Apis regina (queen bee), Argentum metallicum (silver), and Ovaria (bovine ovary extract) in homeopathic dilutions. It is designed to regulate hormonal balance and support ovarian function through stimulatory and regulatory effects on the female endocrine system.
- Brand names
- Ovaria comp
- Other names
- Ovaria comp.
Beyond the preview
Go deeper on Ovaria comp.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ovaria comp.